Company Profile LogoNEUWAY Pharma

NEUWAY is focusing on the preclinical and clinical development of innovative therapeutics for treatment of orphan brain diseases

Edit IconSuggest an Edit
Biotechnology
Health Care
Medical

    Unlock insights on NEUWAY Pharma and 60M+ companies now!

    NEUWAY Pharma Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

    NEUWAY Pharma is committed to bringing transformative neuropharmaceuticals across the blood-brain barrier through its EnPC®, the drug delivery technology based on a natural derived protein capsule. In addition to advancing its proprietary pipeline, the company aims to be a partner of choice in particular for antibody and mRNA drug developers stymied by the hurdles of delivering these and other drug modalities into the brain and CNS tissue. Operating as a drug developer and a delivery expert, NE

    Company Highlights
    Year Founded

    2014

    icon-altEmployees

    13

    Location (HQ)

    DEU

    Since Last Funding

    9 years

    Monthly Website Visitors

    745

    icon-altTotal Investment Amt

    $7.1M

    Last Funding Round

    Series A

    icon-altYoY Headcount Growth

    -18.63%

    Key Metrics

    Senior Hires

    NameLinkedin ProfilePositionDate Joined
    John Doehttps://www.linkedin.com/in/johndoeCEOCEO
    Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
    John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
    Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
    Get API access to complete private company database with growth metrics from 15 sources

    Similar Companies

    Research Services

    Medical

    Health Care

    Biotechnology

    Research